These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38359293)

  • 1. Cysteine induces mitochondrial reductive stress in glioblastoma through hydrogen peroxide production.
    Noch EK; Palma L; Yim I; Bullen N; Barnett D; Walsh A; Bhinder B; Benedetti E; Krumsiek J; Gurvitch J; Khwaja S; Atlas D; Elemento O; Cantley LC
    Proc Natl Acad Sci U S A; 2024 Feb; 121(8):e2317343121. PubMed ID: 38359293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Acetyl-L-Cysteine (NAC) Blunts Axitinib-Related Adverse Effects in Preclinical Models of Glioblastoma.
    Formato A; Salbini M; Orecchini E; Pellegrini M; Buccarelli M; Vitiani LR; Giannetti S; Pallini R; D'Alessandris QG; Lauretti L; Martini M; De Falco V; Levi A; Falchetti ML; Mongiardi MP
    Cancer Med; 2024 Oct; 13(19):e70279. PubMed ID: 39377544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-targeting of aberrant glucose metabolism in glioblastoma.
    Shen H; Decollogne S; Dilda PJ; Hau E; Chung SA; Luk PP; Hogg PJ; McDonald KL
    J Exp Clin Cancer Res; 2015 Feb; 34(1):14. PubMed ID: 25652202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity.
    Altinoz MA; Ucal Y; Yilmaz MC; Kiris İ; Ozisik O; Sezerman U; Ozpinar A; Elmaci İ
    Cancer Med; 2020 Aug; 9(16):5767-5780. PubMed ID: 32590878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Targeting of Transcription and Metabolism in Glioblastoma.
    Su YT; Chen R; Wang H; Song H; Zhang Q; Chen LY; Lappin H; Vasconcelos G; Lita A; Maric D; Li A; Celiku O; Zhang W; Meetze K; Estok T; Larion M; Abu-Asab M; Zhuang Z; Yang C; Gilbert MR; Wu J
    Clin Cancer Res; 2018 Mar; 24(5):1124-1137. PubMed ID: 29254993
    [No Abstract]   [Full Text] [Related]  

  • 6. The Anti-Warburg Effect Elicited by the cAMP-PGC1α Pathway Drives Differentiation of Glioblastoma Cells into Astrocytes.
    Xing F; Luan Y; Cai J; Wu S; Mai J; Gu J; Zhang H; Li K; Lin Y; Xiao X; Liang J; Li Y; Chen W; Tan Y; Sheng L; Lu B; Lu W; Gao M; Qiu P; Su X; Yin W; Hu J; Chen Z; Sai K; Wang J; Chen F; Chen Y; Zhu S; Liu D; Cheng S; Xie Z; Zhu W; Yan G
    Cell Rep; 2017 Jan; 18(2):468-481. PubMed ID: 28076790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction.
    Khan M; Yi F; Rasul A; Li T; Wang N; Gao H; Gao R; Ma T
    IUBMB Life; 2012 Sep; 64(9):783-94. PubMed ID: 22837216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression.
    Tseng JH; Chen CY; Chen PC; Hsiao SH; Fan CC; Liang YC; Chen CP
    Oncotarget; 2017 Feb; 8(9):14666-14679. PubMed ID: 28108734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development.
    Brown KE; Chagoya G; Kwatra SG; Yen T; Keir ST; Cooter M; Hoadley KA; Rasheed A; Lipp ES; Mclendon R; Ali-Osman F; Bigner DD; Sampson JH; Kwatra MM
    J Neurochem; 2015 Jun; 133(5):730-8. PubMed ID: 25598002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylcysteine decreases malignant characteristics of glioblastoma cells by inhibiting Notch2 signaling.
    Deng J; Liu AD; Hou GQ; Zhang X; Ren K; Chen XZ; Li SSC; Wu YS; Cao X
    J Exp Clin Cancer Res; 2019 Jan; 38(1):2. PubMed ID: 30606241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs.
    Jiang P; Mukthavaram R; Chao Y; Bharati IS; Fogal V; Pastorino S; Cong X; Nomura N; Gallagher M; Abbasi T; Vali S; Pingle SC; Makale M; Kesari S
    J Transl Med; 2014 Jan; 12():13. PubMed ID: 24433351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma.
    Kang H; Lee S; Kim K; Jeon J; Kang SG; Youn H; Kim HY; Youn B
    J Exp Clin Cancer Res; 2021 Sep; 40(1):282. PubMed ID: 34488821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O
    Schoenfeld JD; Sibenaller ZA; Mapuskar KA; Wagner BA; Cramer-Morales KL; Furqan M; Sandhu S; Carlisle TL; Smith MC; Abu Hejleh T; Berg DJ; Zhang J; Keech J; Parekh KR; Bhatia S; Monga V; Bodeker KL; Ahmann L; Vollstedt S; Brown H; Shanahan Kauffman EP; Schall ME; Hohl RJ; Clamon GH; Greenlee JD; Howard MA; Schultz MK; Smith BJ; Riley DP; Domann FE; Cullen JJ; Buettner GR; Buatti JM; Spitz DR; Allen BG
    Cancer Cell; 2017 Apr; 31(4):487-500.e8. PubMed ID: 28366679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological inhibition of serine synthesis enhances temozolomide efficacy by decreasing O
    Jin L; Kiang KM; Cheng SY; Leung GK
    Lab Invest; 2022 Feb; 102(2):194-203. PubMed ID: 34625658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of reductase systems by 2-AAPA modulates peroxiredoxin oxidation and mitochondrial function in A172 glioblastoma cells.
    de Souza LF; Schmitz AE; da Silva LCS; de Oliveira KA; Nedel CB; Tasca CI; de Bem AF; Farina M; Dafre AL
    Toxicol In Vitro; 2017 Aug; 42():273-280. PubMed ID: 28461233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
    Conti S; Vexler A; Edry-Botzer L; Kalich-Philosoph L; Corn BW; Shtraus N; Meir Y; Hagoel L; Shtabsky A; Marmor S; Earon G; Lev-Ari S
    PLoS One; 2018; 13(7):e0198627. PubMed ID: 29969452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways.
    Bijangi-Vishehsaraei K; Reza Saadatzadeh M; Wang H; Nguyen A; Kamocka MM; Cai W; Cohen-Gadol AA; Halum SL; Sarkaria JN; Pollok KE; Safa AR
    J Neurosurg; 2017 Dec; 127(6):1219-1230. PubMed ID: 28059653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The angiogenic switch leads to a metabolic shift in human glioblastoma.
    Talasila KM; Røsland GV; Hagland HR; Eskilsson E; Flønes IH; Fritah S; Azuaje F; Atai N; Harter PN; Mittelbronn M; Andersen M; Joseph JV; Hossain JA; Vallar L; Noorden CJ; Niclou SP; Thorsen F; Tronstad KJ; Tzoulis C; Bjerkvig R; Miletic H
    Neuro Oncol; 2017 Mar; 19(3):383-393. PubMed ID: 27591677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties.
    Arif T; Krelin Y; Nakdimon I; Benharroch D; Paul A; Dadon-Klein D; Shoshan-Barmatz V
    Neuro Oncol; 2017 Jul; 19(7):951-964. PubMed ID: 28339833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
    Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.